Sign Up to like & get
recommendations!
0
Published in 2020 at "Medicina"
DOI: 10.3390/medicina57010009
Abstract: Background and Objectives: Aripiprazole is a first-line agent in the treatment of bipolar disorder (BD) and available data demonstrates its efficacy on clinical symptoms in serotonin reuptake inhibitors-resistant obsessive-compulsive disorder (OCD) patients. Therefore, aripiprazole augmentation…
read more here.
Keywords:
obsessive compulsive;
disorder;
mood stabilizers;
augmentation mood ... See more keywords